Implantable Migraine Therapy System

About ShiraTronics

ShiraTronics is a clinical-stage neuromodulation company targeting the large and underserved chronic migraine market. Its core innovation is a fully implantable, head-based neurostimulation system that simultaneously targets both occipital and supraorbital nerve pathways. The company is currently advancing its lead program through the RELIEV-CM2 pivotal clinical trial in the United States and Australia, building on preliminary data from an earlier study. As a private, pre-revenue entity, its near-term success hinges on clinical trial outcomes and subsequent regulatory clearance.

Therapeutic Areas

Other Chronic Migraine Drugs